000 01759 a2200553 4500
005 20250515023611.0
264 0 _c20060818
008 200608s 0 0 eng d
022 _a0022-3417
024 7 _a10.1002/path.1991
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDhawan, D
245 0 0 _aEvidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
_h[electronic resource]
260 _bThe Journal of pathology
_cJul 2006
300 _a336-43 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCarcinoma, Transitional Cell
_xgenetics
650 0 4 _aDNA Methylation
650 0 4 _aDNA, Neoplasm
_xgenetics
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aKeratin-20
650 0 4 _aKeratins
_xmetabolism
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aNeoplasm Staging
650 0 4 _aPolymerase Chain Reaction
_xmethods
650 0 4 _aPromoter Regions, Genetic
650 0 4 _aSurvival Analysis
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
650 0 4 _aUrinary Bladder Neoplasms
_xgenetics
700 1 _aHamdy, F C
700 1 _aRehman, I
700 1 _aPatterson, J
700 1 _aCross, S S
700 1 _aFeeley, K M
700 1 _aStephenson, Y
700 1 _aMeuth, M
700 1 _aCatto, J W F
773 0 _tThe Journal of pathology
_gvol. 209
_gno. 3
_gp. 336-43
856 4 0 _uhttps://doi.org/10.1002/path.1991
_zAvailable from publisher's website
999 _c16242716
_d16242716